| Net loss | |
| Depreciation and amortization | |
| Other amortization | |
| Pension settlement expense | |
| Share-based compensation expense | 6.15M |
| Provision for losses on accounts receivable | 787K |
| Deferred income tax benefit | 14.2M |
| Gain on sale of property and equipment | -2.58M |
| Receivables | -18.91M |
| Prepaid expenses | 1.11M |
| Other assets | -3.66M |
| Income taxes | |
| Accounts payable, accrued expenses and other liabilities | |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | |
| Purchases of property, plant and equipment, net of capital leases and notes payable | -45.77M |
| Proceeds from sales of property and equipment | 7.3M |
| Purchases of short-term investments | -51.76M |
| Proceeds from sales of short-term investments | 54.03M |
| Capitalization of internally developed software and other | -7.66M |
| NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES | |
| Payments on long-term debt | -36.58M |
| Proceeds from issuance of long-term debt | |
| Net change in bank overdraft | |
| Change in restricted cash equivalents and short-term investments | |
| Deferred financing costs | 0 |
| Payment of common stock dividends | -6.25M |
| Proceeds from the exercise of stock options and other | |
| NET CASH USED IN FINANCING ACTIVITIES | |
| NET INCREASE IN CASH AND CASH EQUIVALENTS | |
| Cash and cash equivalents at beginning of period | 164.97M |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | 130.4M |
| Accruals for equipment received | 9.39M |
| Equipment financed under capital leases and notes payable | |